• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatocellular carcinoma: asphyxiate and then cook.

作者信息

Kolly Philippe, Dufour Jean-François

机构信息

Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland.

University Clinic for Visceral Surgery & Medicine, Inselspital Bern, Bern, Switzerland.

出版信息

Hepat Oncol. 2016 Jan;3(1):1-3. doi: 10.2217/hep.15.31. Epub 2015 Nov 6.

DOI:10.2217/hep.15.31
PMID:30191021
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6095311/
Abstract
摘要

相似文献

1
Hepatocellular carcinoma: asphyxiate and then cook.肝细胞癌：先使其窒息，然后再进行处理。 （此翻译仅供参考，具体含义可能需结合更详细的医学背景来准确理解，原文表述比较奇特，似乎不是常规的医学专业表述完整句子）
Hepat Oncol. 2016 Jan;3(1):1-3. doi: 10.2217/hep.15.31. Epub 2015 Nov 6.
2
Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.经导管动脉化疗栓塞联合或不联合射频消融治疗巴塞罗那临床肝癌分期 B 期肝细胞癌的疗效比较。
AJR Am J Roentgenol. 2018 Apr;210(4):891-898. doi: 10.2214/AJR.17.18177. Epub 2018 Feb 7.
3
Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.经导管动脉化疗栓塞术联合射频消融术治疗中国肝细胞癌患者的长期疗效
Curr Med Res Opin. 2015 Aug;31(8):1553-60. doi: 10.1185/03007995.2015.1058249. Epub 2015 Jul 9.
4
Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.早期肝细胞癌不适于超声引导射频消融治疗：单纯经动脉化疗栓塞治疗与联合经动脉化疗栓塞和射频消融治疗的比较。
Cardiovasc Intervent Radiol. 2016 Mar;39(3):417-25. doi: 10.1007/s00270-015-1194-0. Epub 2015 Aug 6.
5
Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.经动脉化疗栓塞联合射频消融治疗早期肝细胞癌。
Korean J Intern Med. 2016 Mar;31(2):242-52. doi: 10.3904/kjim.2015.112. Epub 2016 Feb 15.
6
Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy.经动脉化疗栓塞术（TACE）联合射频消融术（RFA）治疗小肝细胞癌：与 TACE 或 RFA 单药治疗的比较。
Abdom Radiol (NY). 2019 Jun;44(6):2283-2292. doi: 10.1007/s00261-019-01952-1.
7
Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.经动脉化疗栓塞术与射频消融术治疗不可切除的巴塞罗那临床肝癌分期0/A期肝细胞癌的比较：倾向评分匹配法
J Gastroenterol Hepatol. 2016 Feb;31(2):442-9. doi: 10.1111/jgh.13077.
8
Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.经动脉化疗栓塞术与射频消融术联合治疗中期肝细胞癌的疗效
Scand J Gastroenterol. 2018 Dec;53(12):1575-1583. doi: 10.1080/00365521.2018.1548645. Epub 2018 Dec 21.
9
Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.经导管动脉化疗栓塞联合射频消融治疗巴塞罗那临床肝癌分期 A 或 B 期肝细胞癌患者的临床结局改善，无论肿瘤大小：单中心回顾性病例对照研究结果。
BMC Cancer. 2019 Oct 22;19(1):983. doi: 10.1186/s12885-019-6237-5.
10
Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.经肝动脉化疗栓塞（TACE）后碘油残留的局部复发性肝细胞癌的全肿瘤消融可改善无进展生存期。
Eur Radiol. 2019 Sep;29(9):5052-5062. doi: 10.1007/s00330-018-5993-y. Epub 2019 Feb 15.

本文引用的文献

1
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.经动脉化疗栓塞联合射频消融可延缓中期（巴塞罗那临床肝癌分期B期）肝细胞癌患者的肿瘤进展并延长总生存期。
BMC Cancer. 2014 Nov 19;14:849. doi: 10.1186/1471-2407-14-849.
2
Hepatocellular carcinoma: clinical frontiers and perspectives.肝细胞癌：临床前沿与展望。
Gut. 2014 May;63(5):844-55. doi: 10.1136/gutjnl-2013-306627. Epub 2014 Feb 14.
3
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.中危（BCLC B）期肝细胞癌患者的异质性：提出一种亚分类以促进治疗决策。
Semin Liver Dis. 2012 Nov;32(4):348-59. doi: 10.1055/s-0032-1329906. Epub 2013 Feb 8.
4
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.射频消融联合或不联合经导管动脉化疗栓塞治疗肝细胞癌：一项前瞻性随机试验。
J Clin Oncol. 2013 Feb 1;31(4):426-32. doi: 10.1200/JCO.2012.42.9936. Epub 2012 Dec 26.
5
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
6
Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.中等大小（3.1-5.0 厘米）肝细胞癌：经动脉化疗栓塞联合射频消融与单纯射频消融的比较。
Ann Surg Oncol. 2011 Jun;18(6):1624-9. doi: 10.1245/s10434-011-1673-8. Epub 2011 Mar 29.
7
Management of hepatocellular carcinoma: an update.肝细胞癌的管理：最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
8
Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.中大型肝细胞癌患者的中期结果：一项随机对照试验，旨在确定射频消融联合经导管动脉化疗栓塞的疗效。
Cancer. 2010 Dec 1;116(23):5452-60. doi: 10.1002/cncr.25314. Epub 2010 Jul 29.
9
Loco-regional treatment of hepatocellular carcinoma.局部区域治疗肝细胞癌。
Hepatology. 2010 Aug;52(2):762-73. doi: 10.1002/hep.23725.
10
Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.经动脉化疗栓塞术联合经皮消融治疗不可切除肝细胞癌：一项荟萃分析。
Liver Int. 2010 May;30(5):741-9. doi: 10.1111/j.1478-3231.2010.02221.x. Epub 2010 Mar 18.